Abstract
Background: Postoperative pain remains a major clinical challenge, leading to delayed recovery, increased stress response, and prolonged hospital stay. Although opioids like morphine and tramadol are commonly used, their adverse effects have prompted global adoption of multimodal analgesia. Intravenous lignocaine infusion, known for its analgesic and anti-inflammatory properties, has shown promising results internationally but remains underused in Pakistan.
Objective: To compare the frequency of postoperative pain among patients receiving intravenous lignocaine infusion versus those receiving opioid (tramadol) therapy after elective surgeries in tertiary care hospitals of Lahore.
Methodology: A cross-sectional study was conducted over six months (January–June 2025) with a sample of 385 postoperative patients aged 18–65 years undergoing elective abdominal, orthopedic, or gynecological surgeries at tertiary care hospitals of lahore. Pain intensity within 24 hours post-surgery was assessed usi good the Numerical Rating Scale (NRS). Data were analyzed using descriptive statistics as frequency and percentages were used to interpret independent variables.
Results: Preliminary findings showed a lower proportion of moderate to severe pain (NRS ≥4) in the tramadol group compared to the lignocaine infusion group, indicating better pain control.
Conclusion: Intravenous tramadol appears to be an effective, safe, and cost-efficient for postoperative pain management in Pakistan, supporting its inclusion in multimodal analgesia protocols